Evaluation of Endostapled Anastomoses for Laparoscopic Gastric Bypass (EEA-LGB) (EEA-LGB)
Morbid Obesity
About this trial
This is an interventional prevention trial for Morbid Obesity focused on measuring Morbid Obesity, Laparoscopic Gastric Bypass, Staple Line Hemorrhage
Eligibility Criteria
Inclusion Criteria: BMI between 40-60 kg/m2 BMI of 35 kg/m2 with comorbidities Exclusion Criteria: large abdominal ventral hernia large hiatal hernia, history of liver cirrhosis history of venous thrombosis or pulmonary embolism, coagulopathy or Pregnant women All physician, hospital, surgery, and laboratory costs will be billed to the subject or their insurance carriers as customary. The 3.5mm circular stapler is an FDA approved product and it will also be billed to the subject or insurer in the customary fashion.
Sites / Locations
- University of California, Irvine Medical Center
- Tampa General Hospital- University of South Florida
- Beth Israel Deaconess Medical Center
- New York Presbyterian Hospital-Weill Cornell Medical Center
- Ohio State University
- UT Southwestern Medical Center
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Smaller Stapler
Larger Stapler
3.5 mm Circular Stapler
4.8 mm Circular Stapler